Predictors of health-related quality of life in hypertensive recipients following renal transplantation

Clinical Transplantation

Volumn 19, Issue 6, 2005, Pages 756-762

  Aasebø, Willy ^a   Midtvedt, Karsten ^b   Hartmann, Anders ^b   Stavem, Knut ^a,c  

^a AKERSHUS UNIVERSITY HOSPITAL   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

^c Norwegian Hlth Serv Res Centre   (Norway)

Author keywords

Health status; Health related quality of life; Hypertension; Kidney transplantation

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN A; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LISINOPRIL; NIFEDIPINE; PREDNISOLONE;

ADULT; ARTICLE; CADAVER DONOR; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DOUBLE BLIND PROCEDURE; DRUG RESPONSE; FEMALE; FOLLOW UP; HEART FAILURE; HLA TYPING; HUMAN; HYPERTENSION; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LIVING DONOR; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; RECIPIENT; SCORING SYSTEM; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE;

ADULT; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; FEMALE; HEALTH STATUS INDICATORS; HUMANS; HYPERTENSION; KIDNEY TRANSPLANTATION; LINEAR MODELS; LISINOPRIL; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NIFEDIPINE; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIALS;

EID: 28644446434     PISSN: 09020063     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-0012.2005.00416.x     Document Type: Article

References (29)

1. Fiebinger W, Mitterbauer C, Oberbauer R. Health-related quality of life outcomes after kidney transplantation. Health Qual Life Outcomes 2004: 2: 2.
2. Keown P. Improving quality of life - the new target for transplantation. Transplantation 2001: 72(Suppl. 12): 67.
3. Cameron JI, Whiteside C, Katz J, Devins GM. Differences in quality of life across renal replacement therapies: a meta-analytic comparison. Am J Kidney Dis 2000: 35: 629.
4. Rebollo P, Ortega F, Baltar JM et al. Health related quality of life (HRQOL) of kidney transplanted patients: variables that influence it. Clin Transplant 2000: 14: 199.
5. Terada I, Hyde C. The SF-36: an instrument for measuring quality of life in ESRD patients. EDTNA ERCA J 2002: 28: 73.
6. Jofre R, Lopez-Gomez JM, Moreno F, Sanz-Guajardo D, Valderrabano F. Changes in quality of life after renal transplantation. Am J Kidney Dis 1998: 32: 93.
7. Russell JD, Beecroft ML, Ludwin D, Churchill DN. The quality of life in renal transplantation - a prospective study. Transplantation 1992: 54: 656.
8. Evans RW, Hart LG, Manninen DL. A comparative assessment of the quality of life of successful kidney transplant patients according to source of graft. Transplant Proc 1984: 16: 1353.
9. Kizilisik AT, Feurer ID, VanBuren DH et al. Effects of diabetes and cadaveric organs on functional performance and health-related quality of life after kidney transplantation. Am J Surg 2003: 186: 535.
10. Griva K, Ziegelmann JP, Thompson D et al. Quality of life and emotional responses in cadaver and living renal transplant recipients. Nephrol Dial Transplant 2002: 17: 2204.
11. Aakhus S, Dahl K, Wideroe TE. Cardiovascular morbidity and risk factors in renal transplant patients. Nephrol Dial Transplant 1999: 14: 648.
12. Lindholm A, Albrechtsen D, Frodin L et al. Ischemic heart disease - major cause of death and graft loss after renal transplantation in Scandinavia. Transplantation 1995: 60: 451.
13. First MR, Neylan JF, Rocher LL, Tejani A. Hypertension after renal transplantation. J Am Soc Nephrol 1994: 4(Suppl. 8): 30.
14. Sanders CEJ, Curtis JJ. Role of hypertension in chronic renal allograft dysfunction. Kidney Int Suppl 1995: 52: 43.
15. Midtvedt K, Ihlen H, Hartmann A et al. Reduction of left ventricular mass by lisinopril and nifedipine in hypertensive renal transplant recipients: a prospective randomized double-blind study. Transplantation 2001: 72: 107.
16. Midtvedt K, Hartmann A, Foss A et al. Sustained improvement of renal graft function in hypertensive renal transplant recipients treated with nifedipine as compared to lisinopril. Clin Transplant 2001: 72: 1787.
17. Ware JE Jr, Snow KK, Gandek B. SF-36 Health Survey. Manual and Interpretation Guide. Boston, MA, USA: The Health Institute, New England Medical Center, 1993.
18. Mingardi G, Cornalba L, Cortinovis E, Ruggiata R, Mosconi P, Apolone G. Health-related quality of life in dialysis patients. A report from an Italian study using the SF-36 Health Survey. DIA-QOL Group. Nephrol Dial Transplant 1999: 14: 1503.
19. de Jonge P, Ruinemans GM, Huyse FJ, ter Wee PM. A simple risk score predicts poor quality of life and nonsurvival at 1 year follow-up in dialysis patients. Nephrol Dial Transplant 2003: 18: 2622.
20. Mittal SK, Ahern L, Flaster E, Mittal VS, Maesaka JK, Fishbane S. Self-assessed quality of life in peritoneal dialysis patients. Am J Nephrol 2001: 21: 215.
21. Caskey FJ, Wordsworth S, Ben T et al. Early referral and planned initiation of dialysis: what impact on quality of life? Nephrol Dial Transplant 2003: 18: 1330.
22. Ware J, Kosinski M, Keller SD. SF-36 Physical and Mental Health Summary Scales: a Users Manual. Boston, MA, USA: The Health Institute, New England Medical Center, 1994.
23. Aaronson NK, Acquadro C, Alonso J et al. International Quality of Life Assessment (IQOLA) Project. Qual Life Res 1992: 1: 349.
24. Loge JH, Kaasa S. Short form 36 (SF-36) health survey: normative data from the general Norwegian population. Scand J Soc Med 1998: 26: 250.
25. Aasberg A, Midtvedt K, Vassbotn T, Hartmann A. Better microvascular function on long-term treatment with lisinopril than with nifedipine in renal transplant recipients. Nephrol Dial Transplant 2001: 16: 1465.
26. Taft C, Karlsson J, Sullivan M. Do SF-36 summary component scores accurately summarize subscale scores? Qual Life Res 2001: 10: 395.
27. Christensen AJ, Raichle K, Ehlers SL, Bertolatus JA. Effect of family environment and donor source on patient quality of life following renal transplantation. Health Psychol 2002: 21: 468.
28. Shield CF, McGrath MM, Goss TF. Assessment of health related quality of life in kidney transplant patients receiving tacrolimus. (FK506)-based versus cyclosporine-based immunosuppression. FK506 kidney transplant study groups. Transplantation 1997: 16: 113.
29. Karam VH, Gasquet I, Delvart V et al. Quality of life in adult survivors beyond 10 years after liver, kidney, and heart transplantation. Transplantation 2003: 76: 1699.